317 related articles for article (PubMed ID: 36697261)
1. Targeting splicing factors for cancer therapy.
Bashari A; Siegfried Z; Karni R
RNA; 2023 Apr; 29(4):506-515. PubMed ID: 36697261
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of RNA Splicing in Cancer.
Bonner EA; Lee SC
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510283
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of splicing in cancer.
Lee SC; Abdel-Wahab O
Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of spliceosome in cancer and immunity.
Yang H; Beutler B; Zhang D
Protein Cell; 2022 Aug; 13(8):559-579. PubMed ID: 34196950
[TBL] [Abstract][Full Text] [Related]
5. Non-canonical functions of spliceosome components in cancer progression.
Ivanova OM; Anufrieva KS; Kazakova AN; Malyants IK; Shnaider PV; Lukina MM; Shender VO
Cell Death Dis; 2023 Feb; 14(2):77. PubMed ID: 36732501
[TBL] [Abstract][Full Text] [Related]
6. Targeting splicing abnormalities in cancer.
Agrawal AA; Yu L; Smith PG; Buonamici S
Curr Opin Genet Dev; 2018 Feb; 48():67-74. PubMed ID: 29136527
[TBL] [Abstract][Full Text] [Related]
7. Splicing-factor alterations in cancers.
Anczuków O; Krainer AR
RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
[TBL] [Abstract][Full Text] [Related]
8. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing.
Dvinge H; Guenthoer J; Porter PL; Bradley RK
Genome Res; 2019 Oct; 29(10):1591-1604. PubMed ID: 31434678
[TBL] [Abstract][Full Text] [Related]
9. Spliceosomal factor mutations and mis-splicing in MDS.
Hershberger CE; Daniels NJ; Padgett RA
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101199. PubMed ID: 33038983
[TBL] [Abstract][Full Text] [Related]
10. Aberrant RNA splicing and therapeutic opportunities in cancers.
Yamauchi H; Nishimura K; Yoshimi A
Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550
[TBL] [Abstract][Full Text] [Related]
11. SnapShot: Splicing Alterations in Cancer.
Rahman MA; Krainer AR; Abdel-Wahab O
Cell; 2020 Jan; 180(1):208-208.e1. PubMed ID: 31951519
[TBL] [Abstract][Full Text] [Related]
12. Identification of phenothiazine derivatives as UHM-binding inhibitors of early spliceosome assembly.
Jagtap PKA; Kubelka T; Soni K; Will CL; Garg D; Sippel C; Kapp TG; Potukuchi HK; Schorpp K; Hadian K; Kessler H; Lührmann R; Hausch F; Bach T; Sattler M
Nat Commun; 2020 Nov; 11(1):5621. PubMed ID: 33159082
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations.
Urrutia S; Li Z; Almanza E; Bataller A; Kanagal-Shamanna R; Senapati J; Sasaki K; Chien K; Montalban-Bravo G; DiNardo C; Borthakur G; Bueso-Ramos C; Pierce S; Kantarjian H; Garcia-Manero G
Leukemia; 2023 Jun; 37(6):1397-1400. PubMed ID: 37185307
[No Abstract] [Full Text] [Related]
14. Targeting the spliceosome machinery: A new therapeutic axis in cancer?
Eymin B
Biochem Pharmacol; 2021 Jul; 189():114039. PubMed ID: 32417188
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing in Alzheimer's disease.
Biamonti G; Amato A; Belloni E; Di Matteo A; Infantino L; Pradella D; Ghigna C
Aging Clin Exp Res; 2021 Apr; 33(4):747-758. PubMed ID: 31583531
[TBL] [Abstract][Full Text] [Related]
16. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
Urbanski LM; Leclair N; Anczuków O
Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
[TBL] [Abstract][Full Text] [Related]
17. Biological relevance of alternative splicing in hematologic malignancies.
Szelest M; Giannopoulos K
Mol Med; 2024 May; 30(1):62. PubMed ID: 38760666
[TBL] [Abstract][Full Text] [Related]
18. Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches.
Armstrong RN; Steeples V; Singh S; Sanchi A; Boultwood J; Pellagatti A
Adv Biol Regul; 2018 Jan; 67():13-29. PubMed ID: 28986033
[TBL] [Abstract][Full Text] [Related]
19. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
20. Variant snRNPs: New players within the spliceosome system.
Vazquez-Arango P; O'Reilly D
RNA Biol; 2018 Jan; 15(1):17-25. PubMed ID: 28876172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]